Survival in patients with hepatocellular carcinoma treated with 90Y-microsphere radioembolization

Abstract

Pre- and post-therapeutic FDG PET independently predicts overall survival in patients with HCC undergoing radioembolization. Interestingly, early metabolic response seems to be assessable as early as four weeks post-treatment.